Back to Top Skip to main content Skip to sub-navigation

Policies

Find Military Health Affairs and Defense Health Agency policy documents.

If you're having trouble finding what you're looking for, consider using fewer words in your search criteria. Results are limited to content that matches all terms in the search field.

We found - potentially matching "6025.01"

Specify Date Range (Optional):
Select Content Types (Optional):
Current Filters. Click a Filter to Remove It
Date Range:

DHA PM 6025-01: Primary Care Behavioral Health (PCBH) Standards

Policy

This Defense Health Agency-Procedures Manual (DHA-PM), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (i), establishes the Defense Health Agency’s (DHA) procedures to establish required standards for: a. Military Medical Treatment Facilities (MTFs) and primary care clinics for adult, child and adolescent, health behavior, behavioral medicine, and behavioral health services in primary care. b. Behavioral Health Consultants (BHCs). c. Behavioral Health Care Facilitators (BHCFs). d. External Behavioral Health Consultants (EBHCs). e. Primary Care Clinic Leaders.

DHA-PM 6025-13: “Clinical Quality Management in the Military Health System,” Volumes 1-7

Policy

This Defense Health Agency-Procedures Manual (DHA-PM), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (ab), establishes the Defense Health Agency’s (DHA’s) procedures to assign responsibilities and establish procedures for managing Clinical Quality Management (CQM) in the Military Health System (MHS). This DHA-PM replaces, in full, the contents of the DoD Manual 6025.13 (Reference (e)), which is targeted for cancellation. This DHA-PM, replaces, in Volume 2, the full contents, unless otherwise stated, of the following memorandums, which are targeted for cancellation: Assistant Secretary of Defense for Health Affairs Memorandum, "Policy on Reporting Joint Commission on Accreditation of Healthcare Organizations-Reviewable Sentinel Events in the Military Health System," July 13, 2004 (Reference (h)); Assistant Secretary of Defense for Health Affairs Memorandum, "Amplifying Guidance Relating to the Reporting of Sentinel Events and Personally Identifiable Information Breaches to the Office of the Assistant Secretary of Defense (Health Affairs)," February 13, 2012 (Reference (i)) [as related to the reporting of sentinel events only]; and Assistant Secretary of Defense for Health Affairs Memorandum, "Medical Quality Assurance and Clinical Quality Management in the Military Health System Sentinel Event and Root Cause Analysis Process Improvements," March 12, 2015 (Reference (j)).

DHA-MSR 6025.01

Policy

This Defense Health Agency-Multi-Service Regulation (DHA-MSR), based on the authority of References (a) through (c), and in accordance with the guidance of References (d) through (h) and (j): a. Establishes the Defense Health Agency’s (DHA) procedures to be followed when recalls (All Food and Drug Activity (ALFOODACT) messages) are issued for hazardous food, nonprescription drugs, dietary supplements, nonprescription medical devices, health and beauty aid items, and pet food which may be in military accounts (hereinafter referred to as “hazardous food and nonprescription drugs”). b. Ensures the expeditious identification, segregation, and reporting of recalled items is performed at all applicable DoD food supply levels. c. Cancels and replaces AR 40-660/DLAR 4155.26/NAVSUPINST 10110.8C/AFR 161.42/MCO 10110.38C, “DoD Hazardous Food and Nonprescription Drug Recall System,” all editions (Reference (i)).

  • Identification #: DHA-MSR 6025.01
  • Date: 9/7/2018
  • Type: Administrative Instructions
  • Topics: N/A

DHA PI 6025.08: Pharmacy Enterprise Activity EA

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI): a. Based on the authority of References (a) through (c), and in accordance with the guidance of References (d) through (g), establishes the Defense Health Agency’s (DHA) procedures to: (1) Exercise management responsibilities for Pharmacy Shared Service/EA functions in the Military Health System (MHS). This DHA-PI is binding on the MHS and supports the Director’s, DHA, responsibility to develop appropriate management models to maximize efficiencies in the activities carried out by DHA. (2) Recognize the Pharmacy Work Group (PWG) as the operational body to implement pharmacy strategies and programs per the Director’s, DHA, guidance. Also, develop strategic initiatives and business process models to optimize pharmacy operations and programs in accordance with Reference (e). (3) Promulgate guidance, define roles, assign responsibilities, and prescribe procedures for the development, coordination, execution, and implementation of standardized Pharmacy Operations and EA procedures within the MHS and Military Departments (MILDEPs). (4) Execute Pharmacy EA assigned responsibilities and functions, and in accordance with Reference (b), when needed, rely on advice and assistance of governance councils established by the Under Secretary of Defense for Personnel and Readiness and the Assistant Secretary of Defense for Health Affairs (ASD(HA)), including senior representatives of the MILDEPs. (5) Provide DHA combat support agency pharmacy functions, in accordance with Reference (b), specifically involving support for operating forces engaged in planning for, or conducting, military operations, including support during conflict or in the conduct of other military activities related to countering threats to U.S. National Security. The Pharmacy EA innovatively manages and standardizes DoD pharmacy operations in a fiscally responsible manner to optimize readiness, improve health, and lower costs through better care. (6) Support baseline knowledge, skills, and abilities for each wartime pharmacy specialty, addressing gaps between peacetime and deployed operational requirements, in collaboration with the MILDEPs, and military Medical Treatment Facility (MTF) pharmacies. (7) Support programs for skills and knowledge assessments and provide for training/retraining opportunities, as needed, for each wartime pharmacy specialty for military MTF pharmacies. (8) Empower enterprise-level pharmacy clinical communities to define, prioritize, and implement “best-in-class” High Reliability Organization practices to enable readiness through decreasing variation, improving outcomes, and positively impacting healthcare in the MHS. (9) Support the scaling and reconfiguring of pharmacy capabilities required to support the forward operating environment; e.g., hospital ship, combat support hospitals, Expeditionary Medical Support. The Services’ Surgeons General will have deployed medical mission command over health services support of pharmacy resources and capabilities at various levels of command and at diverse locations. b. Transforms varied Tri-Service Pharmacy Operations approaches into a single, integrated DHA Pharmacy Program that standardizes pharmacy shared services and optimizes business processes as directed by the National Defense Authorization Act for Fiscal Year 2017, Section 702 (Reference (c)). c. Drives standardization of institutional and operational commands, sustains and improves medical readiness, creates value within the MHS, and achieves interoperability across platforms to deliver better health care to the warfighter, MHS beneficiaries, and build a medically ready force.

DoD Manual 6025.13: Medical Quality Assurance (MQA) and Clinical Quality Management (CQM) in the Military Health System (MHS)

Policy

This manual reissues DoD 6025.13-R (Reference (a)) as a DoD manual in accordance with the authority in DoD Directive (DoDD) 5124.02 (Reference (b)) and DoD Instruction (DoDI) 6025.13 (Reference (c)) and the guidance in DoDI 5025.01 (Reference (d)). It implements policy, assigns responsibilities, and provides procedures for managing DoD MQA and clinical quality management.

  • Identification #: DoD Manual 6025.13
  • Date: 10/29/2013
  • Type: Manual
  • Topics: N/A

DODI 6025.20 Medical Management (Mm) Programs in the Direct Care System (DCS) and Remote Areas

Policy

This instruction: a. Reissues DoD Instruction (DoDI) 6025.20 (Reference (a)), in accordance with the authority in DoD Directive (DoDD) 5124.02 (Reference (b)). b. Implements policy for establishing MM programs within the DCS in accordance with DoDD 1010.10 (Reference (c)), DoDI 6025.13 (Reference (d)), and DoDD 6000.14 (Reference (e)). c. Establishes policy, assigns responsibilities, and prescribes uniform guidelines, procedures, and standards for the implementation of clinical case management (CM) in the Military Health System (MHS), for TRICARE beneficiaries including care of the wounded, ill, and injured (WII) in accordance with the authority in Reference (b) and DoDI 1300.24 (Reference (f)). d. Defines terms for MM, implements polices, assigns responsibilities, and specifies content for activities within the military treatment facilities (MTF). e. Establishes an interdependent MM system between the DCS and purchased care system (PCS) to improve the delivery and the quality of healthcare. f. Incorporates and cancels Directive-Type Memorandum 08-033 (Reference (g)).

  • Identification #: N/A
  • Date: 4/9/2013
  • Type: Instructions
  • Topics: N/A

DODI 6490.08 Command Notification Requirements to Dispel Stigma in Providing Mental Health Care to Service Members

Policy

In accordance with the authority in DoD Directive 5124.02 (Reference (a)), this Instruction: a. Establishes policy, assigns responsibilities, and prescribes procedures for healthcare providers for determining command notification requirements as applied to: (1) Service members’ involvement in mental health care pursuant to paragraph C7.11.1. of DoD 6025.18-R (Reference (b)) and parts 160 and 164 of title 45, Code of Federal Regulations (Reference (c)). (2) Service members voluntarily seeking drug and alcohol abuse education (as distinguished from substance abuse treatment), consistent with DoD Directive 1010.4 (Reference (d)), requiring DoD personnel to receive education pertaining to drug and alcohol abuse. b. Provides guidance for balance between patient confidentiality rights and the commander’s right to know for operation and risk management decisions. c. Incorporates and cancels Directive-Type Memorandum 09-006 (Reference (e)).

  • Identification #: N/A
  • Date: 8/17/2011
  • Type: Instructions
  • Topics: N/A
Showing results 1 - 7 Page 1 of 1

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.